US2015164937A1PendingUtilityA1
Pharmaceutical or nutraceutical composition
Individually held — no corporate assignee on recordPriority: Aug 26, 2009Filed: Nov 21, 2013Published: Jun 18, 2015
Est. expiryAug 26, 2029(~3.1 yrs left)· nominal 20-yr term from priority
Inventors:Jeffrey M. Golini
A61P 3/06A61P 9/06A61P 37/02A61P 9/00A61P 37/08A61P 9/10A61P 39/00A61P 31/14A61P 25/00A61P 29/00A61P 25/16A61P 35/00A61P 31/12A61P 25/28A61P 19/10A61P 21/06A61P 21/00A61P 11/06A23L 33/115A61K 31/718A61K 31/661A61K 33/42A23L 33/105A61K 36/899A23L 33/16A23L 5/00A23L 33/15A61K 36/90A23L 33/19A61K 36/889A61K 38/168A61K 31/198A23L 33/185A23L 33/175A61K 31/337A23L 29/30A61K 33/00A23L 33/30A23V 2002/00A61K 45/06A61K 35/20A23L 33/125A61K 36/185
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a pharmaceutical or nutraceutical composition comprising an alkalized organic substance selected from the group comprising proteins, carbohydrates, lipids, amino acids, vitamins, therapeutic agents and mixtures thereof. Such compositions are useful for treating a range of diseases and conditions. They also give rise to beneficial physiological effects such as, for example, increasing physical strength, muscle mass and endurance.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical or nutraceutical composition consisting of alkalized starch and optionally one or more excipients.
2 . (canceled)
3 . The composition of claim 1 comprising one or more of disodium phosphate, magnesium glycerol phosphate, magnesium stearate, di-potassium phosphate, soda ash, sodium bicarbonate, sodium phosphate and potassium phosphate.
4 . (canceled)
5 . (canceled)
6 . A method for preparing the composition of claim 1 , the method comprising mixing the starch with an a base such that the pH of the resulting composition is between 7 and 15.
7 . (canceled)
8 . A method for treating a disease or condition selected from the group comprising inflammation and inflammatory diseases, diseases or conditions associated with inflammation, congestive heart failure, ischemic heart disease, heart attack, arrhythmia, cardiomyopathy, high cholesterol and/or triglycerides, MELAS, gyrate atrophy, mitochondrial cytopathies, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, stroke, Alzheimer's disease, myopathies, Duchenne's muscular dystrophies, myophosphorylase deficiency (McArdle's disease), neuromuscular disease, muscular dystrophies, rheumatoid arthritis, osteoporosis, gout, hepatitis, cancer, viral infections and autoimmune disorders, the method comprising administering a therapeutically effective amount of an alkalized organic substance selected from the group comprising proteins, carbohydrates, lipids, amino acids, vitamins, therapeutic agents and mixtures thereof, to a subject in need thereof.
9 . A method of claim 8 wherein the method is to treat or prevent inflammation or diseases or conditions associated with inflammation.
10 . A method according to claim 9 wherein the diseases or conditions associated with inflammation are selected from the group comprising asthma, heart disease, gingivitis and autoimmune disorders including lupus.
11 . A method according to claim 9 wherein the alkalized organic substance comprises one or more esterified oils.
12 . A method of increasing physical strength and/or muscle mass in a subject comprising administering an effective amount of an alkalized organic substance selected from the group comprising proteins, carbohydrates, lipids, amino acids, vitamins, therapeutic agents and mixtures thereof.
13 . A method according to claim 12 wherein the alkalized organic substance comprises one or more of protein, glutamine and tribulus terrestris extract.
14 . A method of increasing physical endurance and/or physical efficiency in a subject comprising administering an effective amount of an alkalized organic substance selected from the group comprising proteins, carbohydrates, lipids, amino acids, vitamins, therapeutic agents and mixtures thereof.
15 . A method according to claim 12 wherein the alkalized organic substance comprise one or more of maltodextrin and glutamine.
16 . A method of preparing a subject for physical activity and/or speeding up recovery of a subject after physical activity comprising administering an effective amount of an alkalized organic substance selected from the group comprising proteins, carbohydrates, lipids, amino acids, vitamins, therapeutic agents and mixtures thereof, to a subject in need thereof prior to or following the physical activity.Join the waitlist — get patent alerts
Track US2015164937A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.